Saturday 17 October 2026 Export IBRX’s income statement to Excel — free account

ImmunityBio, Inc.

ImmunityBio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $113.3 million, up 668.3% from fiscal 2024. In the quarter to June 2026, revenue grew 93.9%, EPS fell 120.0%, free cash flow grew 13.4% and total debt rose 57.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

9.18 0.82 −8.20%

Follow IBRX

Alert me

Market cap: $10.6B
P/E: 0.0×
Fwd P/E: −8.1×
Dividend yield: —
F-score: 4/9
Altman Z: −10.16
Beneish M: 4.57
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	3	3	4	5	+8 more TTM periods Free account
ROE Full definition →	122.85%	117.09%	71.15%	55.01%
ROA Full definition →	(192.58%)	(179.83%)	(79.43%)	(78.91%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(208.27%)	(171.67%)	(95.65%)	(86.73%)
Average Days of Receivables Full definition →	117.72	112.03	137.16	141.55
Free Cash Flow per Share Full definition →	(0.27)	(0.29)	(0.34)	(0.34)
Free Cash Flow Full definition →	(288.07)	(298.89)	(308.78)	(324.76)
Capital Expenditures Full definition →	(6.94)	(4.50)	(3.85)	(5.05)
Other line items
Cash ROIC Full definition →	(335.13%)	(157.20%)	(140.14%)	(138.07%)
Accounts Receivable Turnover Full definition →	4.39	4.68	5.04	4.56
Accounts Payable Turnover Full definition →	0.11	0.08	0.11	0.63
Inventory Turnover Full definition →	0.26	0.21	0.16	1.14
Average Days of Payables Full definition →	3,999.67	4,378.44	3,382.43	425.17
Days of Inventory on Hand Full definition →	646.67	213.99	441.10	493.66
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	147.11%	169.04%	192.92%	230.06%
Selling, General and Administrative Expense of Revenue Full definition →	104.11%	115.71%	132.41%	185.34%
Share Based Compensation of Revenue Full definition →	20.70%	25.14%	32.49%	44.94%
Interest Coverage Full definition →	(2.23)	(2.36)	(2.28)	(2.14)
Operating CF/Net income Full definition →	0.28	0.34	0.87	0.92
Depreciation/Fixed assets Full definition →	0.15	0.13	0.14	0.16
Capex/Depreciation Full definition →	(0.42)	(0.31)	(0.25)	(0.24)
Revenue per Share Full definition →	0.16	0.14	0.12	0.09
Operating CF per Share Full definition →	(0.27)	(0.29)	(0.33)	(0.34)
Capex per Share Full definition →	(0.01)	0.00	0.00	(0.01)
Capex to Sales Full definition →	0.04	0.03	0.03	0.06

Show all line items

Columns are period end dates

Stockrow Weekly